Donor FMT

Phase 2Biologic

FFondazione Policlinico Universitario Agostino Gemelli IRCCS

Donor FMT is one of 6 biologic programs targeting Colonization. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ColonizationRecruiting

ColonizationPhase 2

Recruiting

Competition

Competitive Landscape

7 competitors in Colonization

#DrugCompanyPhaseTrials

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Approved

1 2

Allogenic FMT

UUniversity Hospital, Ghent

Phase 3

1 3

Bactroban

PPadagis LLC

Preclinical

4 4

Donor FMT

FFondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2

2 5

Xylitol

JJoseph Zabner

Phase 1

1 6

Pluronic

UUniversity of Virginia

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Colonization2 trials

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 1/2·NCT05791396·36 enrolled

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 1/2·NCT04759001·52 enrolled

Renal Cell Carcinoma1 trial

Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma

Completed·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·Phase 1/2·NCT04758507·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Donor FMT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Donor FMT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Donor FMT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Fondazione Policlinico Universitario Agostino Gemelli IRCCS company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 2[1]
Company: FFondazione Policlinico Universitario Agostino Gemelli IRCCS

Donor FMT

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Colonization2 trials

Renal Cell Carcinoma1 trial

References

Drug Info

Quick Facts

Related News